ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

Oblimersen Combination Improves CLL Survival

December 28, 2007

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

In Brief: Twenty Apply for ICC Director Job, DeVita Says 30 More Centers Needed; PAP Awards To Clark, Fox

March 18, 1983